Podolanczuk AJ, Cottin V. A narrative review of real-world data on the safety of nintedanib in patients with idiopathic pulmonary fibrosis. Adv Ther. 2023;40(5):2038-2050. doi:10.1007 ...

Boehringer Ingelheim was given the opportunity to review the article for medical ... Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Idiopathic pulmonary fibrosis is a chronic, progressive, incurable lung disease, leading to irreversible lung tissue ...

The primary goal of the research will be to understand how dysfunctional lung epithelial cells contribute to causing and perpetuating pulmonary fibrosis, according to the release. These cells ...

"I was diagnosed with pulmonary fibrosis, which is the scarring of the lungs, which, when your lungs are scarred, it's harder for the oxygen to go to your blood, so your blood/oxygen levels drop ...

Identifying Practical Biomarkers Predicting Lung Function and Survival Neuvivo’s biomarker identification study showed results from an analytical review of specific patients with moderate levels ...

with FDA Breakthrough Therapy designation and peer-reviewed validation, supporting a "Strong Buy" rating. Denifanstat's unique FASN inhibition mechanism effectively reduces liver fibrosis ...

Among histologic risk factors, stage 3 (adjusted Hazard ratio (aHR) 2.68, 95% confidence interval (CI) 1.18–6.11) and stage 4 (aHR 6.96, 95% CI 3.55–13.64) fibrosis were associated with ...

With the market already anticipating record sales from Chinese automaker BYD Co., a convincing overseas growth story will be needed to spur the next leg of its peer-beating stock rally. The ...